Your browser doesn't support javascript.
loading
Evaluation of Antigens for Development of a Serological Test for Human African Trypanosomiasis.
Biéler, Sylvain; Waltenberger, Harald; Barrett, Michael P; McCulloch, Richard; Mottram, Jeremy C; Carrington, Mark; Schwaeble, Wilhelm; McKerrow, James; Phillips, Margaret A; Michels, Paul A; Büscher, Philippe; Sanchez, Jean-Charles; Bishop, Richard; Robinson, Derrick R; Bangs, James; Ferguson, Michael; Nerima, Barbara; Albertini, Audrey; Michel, Gerd; Radwandska, Magdalena; Ndung'u, Joseph Mathu.
Affiliation
  • Biéler S; Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland.
  • Waltenberger H; Microcoat Biotechnologie GmbH, Bernried, Germany.
  • Barrett MP; Wellcome Trust Centre for Molecular Parasitology, University of Glasgow, Glasgow, United Kingdom.
  • McCulloch R; Wellcome Trust Centre for Molecular Parasitology, University of Glasgow, Glasgow, United Kingdom.
  • Mottram JC; Wellcome Trust Centre for Molecular Parasitology, University of Glasgow, Glasgow, United Kingdom.
  • Carrington M; University of Cambridge, Cambridge, United Kingdom.
  • Schwaeble W; University of Leicester, Leicester, United Kingdom.
  • McKerrow J; University of California, San Francisco, California, United States of America.
  • Phillips MA; University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.
  • Michels PA; Christian de Duve Institute, Brussels, Belgium.
  • Büscher P; Institute of Tropical Medicine, Antwerp, Belgium.
  • Sanchez JC; Biomedical Proteomics Research Group, University of Geneva, Geneva, Switzerland.
  • Bishop R; International Livestock Research Institute, Nairobi, Kenya.
  • Robinson DR; CNRS UMR-5234, University of Bordeaux, Bordeaux, France.
  • Bangs J; University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
  • Ferguson M; University of Dundee, Dundee, United Kingdom.
  • Nerima B; University of Bern, Bern, Switzerland / Makerere University, Kampala, Uganda.
  • Albertini A; Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland.
  • Michel G; Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland.
  • Radwandska M; Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland.
  • Ndung'u JM; Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland.
PLoS One ; 11(12): e0168074, 2016.
Article in En | MEDLINE | ID: mdl-27936225
ABSTRACT

BACKGROUND:

Control and elimination of human African trypanosomiasis (HAT) can be accelerated through the use of diagnostic tests that are more accurate and easier to deploy. The goal of this work was to evaluate the immuno-reactivity of antigens and identify candidates to be considered for development of a simple serological test for the detection of Trypanosoma brucei gambiense or T. b. rhodesiense infections, ideally both. METHODOLOGY/PRINCIPAL

FINDINGS:

The reactivity of 35 antigens was independently evaluated by slot blot and ELISA against sera from both T. b. gambiense and T. b. rhodesiense infected patients and controls. The antigens that were most reactive by both tests to T. b. gambiense sera were the membrane proteins VSG LiTat 1.3, VSG LiTat 1.5 and ISG64. Reactivity to T. b. rhodesiense sera was highest with VSG LiTat 1.3, VSG LiTat 1.5 and SRA, although much lower than with T. b. gambiense samples. The reactivity of all possible combinations of antigens was also calculated. When the slot blot results of 2 antigens were paired, a VSG LiTat 1.3- ISG75 combination performed best on T. b. gambiense sera, while a VSG LiTat 1.3-VSG LiTat 1.5 combination was the most reactive using ELISA. A combination of SRA and either VSG LiTat 1.3 or VSG LiTat 1.5 had the highest reactivity on T. b. rhodesiense sera according to slot blot, while in ELISA, pairing SRA with either GM6 or VSG LiTat 1.3 yielded the best results.

CONCLUSIONS:

This study identified antigens that were highly reactive to T. b. gambiense sera, which could be considered for developing a serological test for gambiense HAT, either individually or in combination. Antigens with potential for inclusion in a test for T. b. rhodesiense HAT were also identified, but because their reactivity was comparatively lower, a search for additional antigens would be required before developing a test for this form of the disease.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Trypanosomiasis, African / Antigens, Protozoan Type of study: Prognostic_studies Limits: Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2016 Document type: Article Affiliation country: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Trypanosomiasis, African / Antigens, Protozoan Type of study: Prognostic_studies Limits: Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2016 Document type: Article Affiliation country: Switzerland